Market outlook of the immunodiagnostic market in the China
Technavio’s market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare reforms, growing preference for local manufacture of diagnostic devices, and rapidly increasing competition are some of the significant factors that augment growth in this market during the forecast period.
The rising prevalence of infectious and chronic diseases in this region is the primary growth driver for this market. In China, urbanization has led to an increase in the prevalence of chronic diseases like cancer, diabetes, cardiovascular diseases, and tuberculosis. This high prevalence of chronic diseases is envisaged to bolster the need for immunodiagnostic tests, which in turn would result in market growth during the forecast period.
Competitive landscape and key vendors
The immunodiagnostic market in the China is consolidated due to the presence of numerous small, medium, and large vendors. The vendors in this market compete on the basis of product differentiation, application differentiation, portfolio, and pricing to gain maximum market traction during the forecast period.
The top vendors in the market are
- Roche Diagnostics
- Abbott Diagnostics
- Siemens Healthcare Diagnostics
- Beckman Coulter
- Sysmex Medical Electronics (Shangai)
Other prominent vendors in the market include AccuBio Tech,Alere,Becton Dickinson,Beijing Kewei Clinical Diagnostics Reagents, Beijing Leadman Biochemistry,Bio-RadBioscience Diagnostic Technology,Biosino Biotechnology & Science, DIAsource, DiaSys Diagnostic Systems, Fosun Pharma, Getein Biotechnology, Hitachi, Immunodiagnostic System Holdings, Luminex, NewScen Coast Bio-Pharmaceutical, Ortho Clinical Diagnostics, Shanghai Kehua Bio-engineering, Sichuan Maccura Biotechnology, Tecan, and Thermofisher Scientific.
Technological segmentation of the immunodiagnostic market in China
- ELISA
- CLIA
- RIA
- FIA
- MIA
- LFIA
According to this global market research report, the chemiluminescence (CLIA) assay segment is anticipated to be the largest market segment during the forecast period. The ability of this assay to perform clinical applications at a rapid pace is a major factor that augments its adoption during the forecast period. Moreover, this assay’s ability to make sample detection sensitive and easy is envisaged to result in its profound market share of more than 66% by 2020.
Product-type segmentation and analysis of the immunodiagnostic market in China
Technavio market research analysts estimate the reagents segment to account for a market share of approximately 82% during the forecast period. The ability of reagents to diagnose minute quantities of biological agents like hormones, viruses, vitamins, or immunogenic substances in blood samples is anticipated to result in its high adoption during the predicted period.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the immunodiagnostic market in the China?
- What are the key market trends impacting the growth of the immunodiagnostic market in the China?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the immunodiagnostic market in the China?
- What are the key outcomes of the five forces analysis of the immunodiagnostic market in the China?
Related reports
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Healthcare system in China
- Health insurance system in China
- Regulatory landscape of China
- Distribution network in China
PART 06: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 07: Market segmentation by product type
- Immunodiagnostic reagents
- Immunodiagnostic instruments
- Immunodiagnostic reagents market in China
- Immunodiagnostic instruments market in China
PART 08: Market segmentation by analyzer type
PART 09: Market segmentation by mode of operation
PART 10: Market segmentation by technology
- CLIA market in China
- ELISA market in China
- FIA market in China
- MIA market in China
- LFIA market in China
- RIA market in China
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
- Market share analysis
- Analysis of tier 1 vendors
PART 17: Key vendor analysis
- Abbott Diagnostics
- Beckman Coulter Trading (China)
- bioMérieux China
- DiaSorin
- Mindray
- Roche Diagnostics
- Siemens Healthcare Diagnostics (Shanghai)
- Sysmex Medical Electronics (Shanghai)
PART 18: Appendix
PART 19: Explore Technavio